Edges in Network
Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | MSRB3 |
Upstream (Parents) |
---|
(<<) FAP → MSRB3 |
(<<) GLT8D2 → MSRB3 |
(<<) SPARC → MSRB3 |
(<<) FBN1 → MSRB3 |
Downstream (Children) |
---|
MSRB3 → COX7A1 (>>) |
MSRB3 → LOC134466 (>>) |
MSRB3 → CYS1 (>>) |
MSRB3 → FGF1 (>>) |
MSRB3 → CNTN4 (>>) |
MSRB3 → NEXN (>>) |
MSRB3 → LMOD1 (>>) |
MSRB3 → PRKG1 (>>) |
MSRB3 → PRKD1 (>>) |
MSRB3 → PTPN21 (>>) |
MSRB3 → PCDH7 (>>) |
MSRB3 → ISM1 (>>) |
MSRB3 → STMN2 (>>) |
MSRB3 → MYLK (>>) |
MSRB3 → HOXA10 (>>) |
MSRB3 → GLT8D2 (>>) |
MSRB3 → DKK3 (>>) |
MSRB3 → MYL9 (>>) |
MSRB3 → CNN1 (>>) |
MSRB3 → FEZ1 (>>) |
MSRB3 → GJA5 (>>) |
MSRB3 → LAMA4 (>>) |
MSRB3 → FHL2 (>>) |
MSRB3 → BNC2 (>>) |
MSRB3 → HSPA12A (>>) |
MSRB3 → FRMD6 (>>) |
MSRB3 → FBN1 (>>) |
MSRB3 → LAYN (>>) |
MSRB3 → SCG5 (>>) |
MSRB3 → FSTL1 (>>) |
MSRB3 → RPS6KA2 (>>) |
MSRB3 → PALLD (>>) |
MSRB3 → SAMD4A (>>) |
MSRB3 → ACTA2 (>>) |
MSRB3 → IGFBP7 (>>) |
MSRB3 → UACA (>>) |
MSRB3 → TPM2 (>>) |
MSRB3 → MRVI1 (>>) |
MSRB3 → DIXDC1 (>>) |
MSRB3 → LOC728264 (>>) |
MSRB3 → C17orf91 (>>) |